Dr. Vince Willard, Director of Regenerative Therapies, Co-Authors Two Papers on Genetic Engineering

Dr. Vince Willard recently co-authored two papers studying applications of gene editing of stem cells to prevent inflammation. One paper, entitled “CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues,” published in the May 2017 edition of Arthritis & Rheumatology. The other paper, “Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs,” published in the May 2017 edition of Stem Cell Reports.